Suppr超能文献

通过囊胚互补产生的Flk-1基因敲除嵌合小鼠中驻留巨噬细胞的衍生及肿瘤微环境的构建。

Derivation of resident macrophages and construction of tumor microenvironment in Flk-1-knockout chimeric mice produced via blastocyst complementation.

作者信息

Ishii Satoko, Yamazaki Kazuto, Li Peng, Kubara Kenji, Ishizuka Yuta, Izumi Yukina, Kamisako Tsutomu, Ishizaki Hiroyoshi, Ono Yuichi, Mizuno Naoaki, Sato Hideyuki, Masaki Hideki, Watanabe Motoo, Ito Masashi, Nakauchi Hiromitsu

机构信息

Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3, Tokodai, Tsukuba, Ibaraki, 300-2635, Japan.

Kobe Research Laboratories, Eisai Co., Ltd., 6-8-2 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.

出版信息

Sci Rep. 2025 Jul 29;15(1):27665. doi: 10.1038/s41598-025-12571-w.

Abstract

The tumor microenvironment (TME) is deeply involved in cancer progression and treatment resistance. Although humanized mouse models have been developed by transplanting human cells into immunodeficient mice, they fail to fully reconstitute the TME. Blastocyst complementation using Flk-1 (Vegfr2, Kdr) knockout hosts offers a potential solution. However, the generation of interspecies human-mouse chimeras using blastocyst complementation has not yet been successful. As a foundational step, this study aims to demonstrate that donor-derived TME can be constructed using this method in intraspecies chimeric mice. We generated chimeric mice by injecting Azami-Green (AG)-positive C57BL/6 (B6) mouse-derived embryonic stem cells (ESCs) into ICR Flk-1 knockout embryos. We observed that vascular endothelial cells (VECs), hematopoietic cells, and tissue-resident macrophages were derived from the injected AG-positive ESCs. We engrafted B6-derived tumor cells into the chimeras and identified tumor-infiltrating lymphocytes, tumor-associated macrophages, and VECs derived from donor cells. Moreover, tumor-infiltrating CD8 T cells in these chimeric mice showed cytotoxic activity comparable to that in wild-type mice. We anticipate that this intraspecies chimeric mouse model can serve as a valuable tool for basic research. Furthermore, future humanized tumor models generated via blastocyst complementation have the potential to significantly advance anticancer drug development in the preclinical phase.

摘要

肿瘤微环境(TME)与癌症进展和治疗抗性密切相关。尽管通过将人类细胞移植到免疫缺陷小鼠中已开发出人类化小鼠模型,但它们未能完全重建TME。使用Flk-1(Vegfr2,Kdr)基因敲除宿主进行囊胚互补提供了一种潜在的解决方案。然而,利用囊胚互补产生种间人鼠嵌合体尚未成功。作为基础步骤,本研究旨在证明可使用这种方法在种内嵌合小鼠中构建供体来源的TME。我们通过将Azami-Green(AG)阳性的C57BL/6(B6)小鼠来源的胚胎干细胞(ESC)注射到ICR Flk-1基因敲除胚胎中来生成嵌合小鼠。我们观察到血管内皮细胞(VEC)、造血细胞和组织驻留巨噬细胞均来源于注射的AG阳性ESC。我们将B6来源的肿瘤细胞移植到嵌合体中,并鉴定出来自供体细胞的肿瘤浸润淋巴细胞、肿瘤相关巨噬细胞和VEC。此外,这些嵌合小鼠中的肿瘤浸润CD8 T细胞表现出与野生型小鼠相当的细胞毒性活性。我们预计这种种内嵌合小鼠模型可作为基础研究的宝贵工具。此外,未来通过囊胚互补产生的人类化肿瘤模型有可能在临床前阶段显著推进抗癌药物的开发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验